官方服务：
资源简介：
monitor lung cancer patients plasma ctDNA mutations
应用场景：
创建时间：
2017-11-21
相关数据集
ctDNA_Based_结直肠癌治疗进展无创监测临床观察数据
本数据集为结直肠癌（CRC）患者治疗期间循环肿瘤DNA（ctDNA）监测的临床观察数据，通过对6例连续患者的545基因捕获测序，分析原发肿瘤组织与23份系列时间点血浆样本的突变模式及变异等位基因频率（VAF），评估ctDNA作为肿瘤负荷监测指标的价值，对比传统生物标志物及影像学的优势。 论文“Application of circulating tumor DNA as a non-invasiv
海数据50
CRCQV42Run035-10 - samples
Targeted capture ctDNA Library CRCQV42Run035-10 from patient PBC0002872, plasma 12 month sampleEGA dataset EGAD00001010577
NIAID Data Ecosystem30
Modulation of the FOLFIRI-based standard 1st-line therapy with cetuximab, controlled by monitoring the RAS mutation load by liquid biopsy in RAS-mutated mCRC patients
Interventions: Group 1: FOLFIRI or mFOLFIRI (q14d) + cetuximab (q7d): o Irinotecan 180 mg/m² iv, 30 - 90 min, day 1 o Folinic acid (racemic) 400 mg/m² iv, 120 min, day 1 o [5-FU 400 mg/m² bolus, day 1
NIAID Data Ecosystem20
Supplementary Data 1,4 from Circulating Tumor DNA Dynamics and Clinical Outcome in Metastatic Colorectal Cancer Patients Undergoing Front-Line Chemotherapy
Supp Tables
NIAID Data Ecosystem30
MOESM3 of Tracking longitudinal genetic changes of circulating tumor DNA (ctDNA) in advanced Lung adenocarcinoma treated with chemotherapy
Additional file 3: Table S3. Gene list for BGI Oseq-ctDNA.
NIAID Data Ecosystem20
